Logo image of SLE

SUPER LEAGUE ENTERPRISE INC (SLE) Stock Fundamental Analysis

NASDAQ:SLE - Nasdaq - US86804F3010 - Common Stock - Currency: USD

0.142  -0.03 (-15.22%)

After market: 0.145 +0 (+2.11%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SLE. SLE was compared to 71 industry peers in the Interactive Media & Services industry. SLE may be in some trouble as it scores bad on both profitability and health. SLE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SLE has reported negative net income.
SLE had a negative operating cash flow in the past year.
SLE had negative earnings in each of the past 5 years.
SLE had a negative operating cash flow in each of the past 5 years.
SLE Yearly Net Income VS EBIT VS OCF VS FCFSLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

SLE has a worse Return On Assets (-159.55%) than 98.59% of its industry peers.
Industry RankSector Rank
ROA -159.55%
ROE N/A
ROIC N/A
ROA(3y)-181.55%
ROA(5y)-140.01%
ROE(3y)-3511.32%
ROE(5y)-2145.61%
ROIC(3y)N/A
ROIC(5y)N/A
SLE Yearly ROA, ROE, ROICSLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

Looking at the Gross Margin, with a value of 37.89%, SLE is doing worse than 76.06% of the companies in the same industry.
SLE's Gross Margin has declined in the last couple of years.
SLE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.98%
GM growth 5Y-6.5%
SLE Yearly Profit, Operating, Gross MarginsSLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

SLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SLE has been increased compared to 1 year ago.
The number of shares outstanding for SLE has been increased compared to 5 years ago.
Compared to 1 year ago, SLE has a worse debt to assets ratio.
SLE Yearly Shares OutstandingSLE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SLE Yearly Total Debt VS Total AssetsSLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

SLE has an Altman-Z score of -44.08. This is a bad value and indicates that SLE is not financially healthy and even has some risk of bankruptcy.
SLE's Altman-Z score of -44.08 is on the low side compared to the rest of the industry. SLE is outperformed by 92.96% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -44.08
ROIC/WACCN/A
WACC8.35%
SLE Yearly LT Debt VS Equity VS FCFSLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

SLE has a Current Ratio of 0.33. This is a bad value and indicates that SLE is not financially healthy enough and could expect problems in meeting its short term obligations.
SLE has a Current ratio of 0.33. This is amonst the worse of the industry: SLE underperforms 95.77% of its industry peers.
A Quick Ratio of 0.33 indicates that SLE may have some problems paying its short term obligations.
The Quick ratio of SLE (0.33) is worse than 94.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
SLE Yearly Current Assets VS Current LiabilitesSLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.54% over the past year.
Looking at the last year, SLE shows a very negative growth in Revenue. The Revenue has decreased by -43.43% in the last year.
Measured over the past years, SLE shows a very strong growth in Revenue. The Revenue has been growing by 71.84% on average per year.
EPS 1Y (TTM)73.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.68%
Revenue 1Y (TTM)-43.43%
Revenue growth 3Y11.51%
Revenue growth 5Y71.84%
Sales Q2Q%-35.42%

3.2 Future

Based on estimates for the next years, SLE will show a very strong growth in Earnings Per Share. The EPS will grow by 37.95% on average per year.
The Revenue is expected to grow by 9.71% on average over the next years. This is quite good.
EPS Next Y72.93%
EPS Next 2Y37.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.15%
Revenue Next 2Y9.71%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SLE Yearly Revenue VS EstimatesSLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
SLE Yearly EPS VS EstimatesSLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLE. In the last year negative earnings were reported.
Also next year SLE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLE Price Earnings VS Forward Price EarningsSLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLE Per share dataSLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as SLE's earnings are expected to grow with 37.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.95%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUPER LEAGUE ENTERPRISE INC

NASDAQ:SLE (6/3/2025, 8:00:02 PM)

After market: 0.145 +0 (+2.11%)

0.142

-0.03 (-15.22%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-12 2025-08-12
Inst Owners7.39%
Inst Owner Change21.49%
Ins Owners11.36%
Ins Owner Change0%
Market Cap3.43M
Analysts80
Price Target1.4 (885.92%)
Short Float %2.19%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.19%
Min EPS beat(2)-71.36%
Max EPS beat(2)24.99%
EPS beat(4)2
Avg EPS beat(4)-12.01%
Min EPS beat(4)-71.36%
Max EPS beat(4)24.99%
EPS beat(8)5
Avg EPS beat(8)-0.67%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)9.38%
Revenue beat(2)0
Avg Revenue beat(2)-21.96%
Min Revenue beat(2)-38.33%
Max Revenue beat(2)-5.59%
Revenue beat(4)0
Avg Revenue beat(4)-26.48%
Min Revenue beat(4)-38.33%
Max Revenue beat(4)-5.59%
Revenue beat(8)2
Avg Revenue beat(8)-12.4%
Revenue beat(12)2
Avg Revenue beat(12)-12.42%
Revenue beat(16)5
Avg Revenue beat(16)-6.86%
PT rev (1m)0%
PT rev (3m)-38.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-63.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-34.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-35.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.63
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS0.61
BVpS-0.14
TBVpS-0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -159.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.89%
FCFM N/A
ROA(3y)-181.55%
ROA(5y)-140.01%
ROE(3y)-3511.32%
ROE(5y)-2145.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.98%
GM growth 5Y-6.5%
F-Score3
Asset Turnover1.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.1%
Cap/Sales 3.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -44.08
F-Score3
WACC8.35%
ROIC/WACCN/A
Cap/Depr(3y)20.68%
Cap/Depr(5y)37.55%
Cap/Sales(3y)4.74%
Cap/Sales(5y)16.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.68%
EPS Next Y72.93%
EPS Next 2Y37.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.43%
Revenue growth 3Y11.51%
Revenue growth 5Y71.84%
Sales Q2Q%-35.42%
Revenue Next Year-13.15%
Revenue Next 2Y9.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.92%
OCF growth 3YN/A
OCF growth 5YN/A